Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).This article has been retracted at the request of the Editor-in-Chief and the authors, as panels from Figure 6F appear as similar to panels from Figure 2B of the article published by Ming-Quan Gao, Hui Gao, Mei Han, Kai-Li Liu, Jian-Jun Peng and Yan-Tao Han in the American Journal of Cancer Research 7 (2017) 1501–1514 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523031/ and Figures 2E and 3E of the article published by Meizhi Wang, Hui Gao, Haijun Qu, Jing Li, Kaili Liu and Zhiwu Han in Pharmacological Reports 70 (2018) 963–971 https://doi.org/10.1016/j.pharep.2018.04.006.Also, the Vehicle panel from Figure 7E appears as similar to the Vehicle panel from Figure 3D of the article published by Bo Liu and Shuo Yu in Biomedicine & Pharmacotherapy 107 (2018) 243–253 https://doi.org/10.1016/j.biopha.2018.07.177.Figure 7E appears also as similar to Figure 6(b) of the article published by Mei Han, Hui Gao, Jing Xie, Yin-ping Yuan, Quan Yuan, Ming-quan Gao, Kai-li Liu, Xue-hong Chen, Yan-tao Han and Zhi-wu Han in Acta Pharmacologica Sinica volume 40 (2019) 666–676 https://doi.org/10.1038/s41401-018-0159-7.Moreover, panels from Figure 7F appear as similar to panels from Figure 7E of the Reference [1], Figure 6D of the Reference [2], Figure 6C of the Reference [3], Figure 8C of the Reference [4], Figure 8D of the Reference [5] and Figure 6B of the Reference [6].One of the conditions of submission of a paper for publication is that authors declare explicitly that their work is original and has not appeared in a publication elsewhere. Re-use of any data should be appropriately cited. As such this article represents a severe abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.

[Retracted] Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells

[Retracted] In vitro antitumor activity of the ethyl acetate extract Potentilla chinensis in osteosarcoma cancer cells

Daidzein Exerts Anticancer Activity Towards SKOV3 Human Ovarian Cancer Cells by Inducing Apoptosis and Cell Cycle Arrest, and Inhibiting the Raf/MEK/ERK Cascade

[Retracted] Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion

[Retracted] 2,3,5,4‐tetrahydroxy diphenylethylene‐2‐O‐glucoside inhibits the adhesion and invasion of A549 human lung cancer cells

[Retracted] Activating autophagy and ferroptosis of 3‐Chloropropane‐1,2‐diol induces injury of human umbilical vein endothelial cells via AMPK/mTOR/ULK1

[Retracted] Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK

[Retracted] Molecular mechanism of atractylon in the invasion and migration of hepatic cancer cells based on high‐throughput sequencing

[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

[Retracted] Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

[Retracted] Chronic oxymatrine treatment induces resistance and epithelial‐mesenchymal transition through targeting the long non‐coding RNA MALAT1 in colorectal cancer cells

RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

Antitumor Effects of Helenalin in Doxorubicin-Resistant Leukemia Cells Are Mediated Via Mitochondrial Mediated Apoptosis, Loss of Mitochondrial Membrane Potential, Inhibition of Cell Migration and Invasion and Downregulation of PI3-kinase/AKT/m-TOR Signalling Pathway.

[Retracted] MicroRNA‐320 targets mitogen‐activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer

[Retracted] LncRNA HOTAIR controls the expression of Rab22a by sponging miR‐373 in ovarian cancer

[Retracted] Activation of the δ‐opioid receptor inhibits serum deprivation‐induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway

[Retracted] Tripartite motif‐containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway

[Retracted] ANRIL is associated with the survival rate of patients with colorectal cancer, and affects cell migration and invasion in vitro

[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‐JNK‐mediated AKT/mTOR signaling pathway

[Retracted] Zearalenone regulates endometrial stromal cell apoptosis and migration via the promotion of mitochondrial fission by activation of the JNK/Drp1 pathway

[Retracted] EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer